Regulus raises $75M in follow-on

Regulus Therapeutics Inc. (NASDAQ:RGLS) wasted little time cashing in on a recent stock surge, as the microRNA company raised $75 million through the sale of 4.4 million shares at $17 in a follow-on underwritten by Deutsche Bank; BMO; Needham; Wedbush; and FBR.

Regulus proposed the offering after market on Monday, when its share price was $18.47. Regulus surged $6.98 (103%) to $13.75 on Oct. 22 after interim Phase I data showed the company's RG-101 led to significant and sustained viral reductions in HCV patients. ...